Bing Tian, Ph.D.
Bing Tian, Ph.D.
Division of Endocrinology
Department of Internal Medicine
University of Texas Medical Branch
8.138 Medical Research Building
Galveston, TX 77555-1060
Dr. Bing Tian received his Ph.D. in 1999 from UTMB. Dr. Tian has made significant impact in the field of viral-inducible gene regulation by experimentally identifying the spectrum of NF-κB dependent genes in virus infected epithelial cells. Dr. Tian has also extended his work to describe the role of NF-κB in the response to tumor necrosis factor, a potent airway inflammatory cytokine. He has discovered that the genes downstream of NF-κB are activated in distinct temporal waves, and to systematically identify them.
Right now, the research interests of Dr Tian concentrate on signaling mechanism of airway inflammation research projects which include molecular biology, cell biology, biochemical, and dynamic imaging approaches. He is interested in studying the signaling networks in airway epithelial cells in response to viral infection and double stranded RNA exposures and examine the regulation of the innate immune response in well differentiated airway epithelial cells.
The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.Currently available protocols are:
- CAP - Community Acquired Pneumonia Orderset
- Congestive Heart Failure (CHF)
- Chronic Obstructive Pulmonary Disease (COPD)
- Diabetic Ketoacidosis Adult, ICU
- General Medicine Admission
- Immunodeficiency Flow Panel
- MICU/CCU Admission Order Set
- Oral Analgesic Medicaitons
- Parenteral Opioids
- Sepsis, Adult ICU
All protocols can be found in the EPIC order set section.
The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.